Bactroban and Tooth loss - a phase IV clinical study of FDA data

Summary:

Tooth loss is reported as a side effect among people who take Bactroban (mupirocin), especially for people who are male, 40-49 old, also take Xanax, and have Partial seizures.

The phase IV clinical study analyzes which people have Tooth loss when taking Bactroban. It is created by eHealthMe based on reports of 4,919 people who have side effects when taking Bactroban from the FDA, and is updated regularly.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.

What is Tooth loss?

Tooth loss is found to be associated with 1,096 drugs and 942 conditions by eHealthMe. Check the latest studies of Tooth loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

4,919 people reported to have side effects when taking Bactroban.
Among them, 21 people (0.43%) have Tooth loss.

Among these 21 people:

What is the gender of people who have Tooth loss when taking Bactroban? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Tooth loss when taking Bactroban? *

What are other drugs people take besides Bactroban? *

What are other side effects people have besides Tooth loss? *

Stress And Anxiety: 19 people, 90.48%
Oedema Peripheral (superficial swelling): 12 people, 57.14%
Panic Disorder: 12 people, 57.14%
Depression: 12 people, 57.14%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 11 people, 52.38%
Gingivitis (inflammation of gums): 11 people, 52.38%
Fall: 11 people, 52.38%
Drug Ineffective: 11 people, 52.38%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 11 people, 52.38%
Dizziness: 11 people, 52.38%

What are the existing conditions these people have? *

Procedural Pain: 10 people, 47.62%
Partial Seizures (seizures which affect only a part of the brain at onset): 10 people, 47.62%
Neuropathy Peripheral (surface nerve damage): 8 people, 38.10%
Hiv Infection: 8 people, 38.10%
Pain In Extremity: 7 people, 33.33%
Pain: 2 people, 9.52%
Indigestion: 1 person, 4.76%
Bone Disorder: 1 person, 4.76%
Breast Cancer Stage Iii: 1 person, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Bactroban and have Tooth loss?

- Check whether Tooth loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bactroban:

Bactroban (4,967 reports)

Tooth loss treatments and more:

Tooth loss (33,880 reports)

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tooth loss:

Tooth loss (1,096 drugs)

Browse all the conditions that are associated with Tooth loss:

Tooth loss (942 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Bactroban) and Bactroban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.